Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liu

Showing results (321-330 of 420) with videos related to

Pageof 42
Sort By:
Critical Care (London, England)|April 6, 2016
Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trialLars W Andersen, Mathias J Holmberg, Katherine M Berg, et al.
Biomedicines|March 28, 2025
Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory ConvergenceJimi Olaghere, David A Williams, Jeremy Farrar, et al.
Cancer Research|March 5, 2020
<i>ATM</i> Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate CancerShahrzad Rafiei, Kenyon Fitzpatrick, David Liu, et al.
Cardiovascular and Interventional Radiology|May 23, 2007
Radioembolization with 90Y microspheres: angiographic and technical considerationsRobert J Lewandowski, Kent T Sato, Bassel Atassi, et al.
Addiction Science & Clinical Practice|March 22, 2021
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility studyRyan P McCormack, John Rotrosen, Phoebe Gauthier, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanomaTuulia Vallius, Yingxiao Shi, Edward Novikov, et al.
Cytotherapy|July 5, 2025
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and DanaherFyodor Urnov, Sadik Kassim, Kiran Musunuru, et al.
Annals of Emergency Medicine|May 4, 2023
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled TrialRyan P McCormack, John Rotrosen, Phoebe Gauthier, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
YAP1 drives aggressive and therapy resistant state in melanoma through reprogramming the chromatin and regulating immune evasive programsNana Chen, Gracia Bonilla, Abdullah Ai Emran, et al.
Nature|March 15, 2019
Adopt a moratorium on heritable genome editingEric S Lander, Françoise Baylis, Feng Zhang, et al.
Pageof 42

Showing results (321-330 of 420) with videos related to

Sort By:
Pageof 42
Critical Care (London, England)|April 6, 2016
Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trialLars W Andersen, Mathias J Holmberg, Katherine M Berg, et al.
Biomedicines|March 28, 2025
Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory ConvergenceJimi Olaghere, David A Williams, Jeremy Farrar, et al.
Cancer Research|March 5, 2020
<i>ATM</i> Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate CancerShahrzad Rafiei, Kenyon Fitzpatrick, David Liu, et al.
Cardiovascular and Interventional Radiology|May 23, 2007
Radioembolization with 90Y microspheres: angiographic and technical considerationsRobert J Lewandowski, Kent T Sato, Bassel Atassi, et al.
Addiction Science & Clinical Practice|March 22, 2021
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility studyRyan P McCormack, John Rotrosen, Phoebe Gauthier, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanomaTuulia Vallius, Yingxiao Shi, Edward Novikov, et al.
Cytotherapy|July 5, 2025
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and DanaherFyodor Urnov, Sadik Kassim, Kiran Musunuru, et al.
Annals of Emergency Medicine|May 4, 2023
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled TrialRyan P McCormack, John Rotrosen, Phoebe Gauthier, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
YAP1 drives aggressive and therapy resistant state in melanoma through reprogramming the chromatin and regulating immune evasive programsNana Chen, Gracia Bonilla, Abdullah Ai Emran, et al.
Nature|March 15, 2019
Adopt a moratorium on heritable genome editingEric S Lander, Françoise Baylis, Feng Zhang, et al.
Pageof 42